The Benefits of Red Light Therapy for Chemo Hair Loss

Chemotherapy-induced alopecia (CIA) is one of the most visible and emotionally distressing side effects of cancer treatment. While chemo hair loss is often temporary, the psychological impact can be significant for patients already navigating a challenging cancer journey.

Red light therapy, also known as low-level laser therapy (LLLT) or photobiomodulation therapy (PBMT), has emerged as a promising non-invasive treatment that may accelerate hair regrowth after chemotherapy 1 7.

Table of Contents

Understanding Chemotherapy-Induced Hair Loss

Chemo hair loss typically begins one to three weeks after starting chemotherapy treatments. This occurs because chemotherapy targets rapidly dividing cells, including cancer cells and, unfortunately, the cells in hair follicles1.

When these follicle cells are damaged, hair shafts break off close to the scalp, resulting in partial or complete hair loss 5.

CIA doesn’t just affect scalp hair but can also impact eyebrows, eyelashes, facial hair, and body hair. For many patients, this visible side effect becomes a constant reminder of their cancer diagnosis and treatment 1.

How Red Light Therapy Works for Hair Regrowth

Red light therapy uses specific wavelengths of red and near-infrared light (typically 630-670 nm) to stimulate cellular function and promote hair growth. When applied to the scalp, these light waves penetrate the skin and are absorbed by mitochondria in hair follicle cells 4 6.

This process enhances cellular energy production (ATP), improves blood flow to the scalp, reduces inflammation, and stimulates dormant hair follicles 4 8.

Specific Mechanisms for Chemotherapy-Induced Hair Loss

Red light therapy may be particularly effective for chemotherapy-induced hair loss due to several unique mechanisms:

Reduced Apoptosis: Evidence suggests that red light therapy can help reduce apoptosis (programmed cell death) during chemotherapy. Chemo works by inducing apoptosis in cancer cells but can also cause the death of healthy cells, including those in hair follicles 4.
Increased Anti-Apoptotic Proteins: The reduction in apoptosis is likely due to an increased amount of anti-apoptotic proteins in the mitochondria 4.
Stem Cell Activation: Red light therapy may activate stem cells in the hair bulge region, encouraging new growth cycles after chemotherapy damage 5.
Enhanced Cellular Respiration: Red light therapy improves mitochondrial function, supporting more efficient energy production in follicle cells weakened by chemotherapy 6 8.

Clinical Evidence Supporting Red Light Therapy for CIA

Recent clinical trials have shown promising results for red light therapy in treating chemotherapy-induced hair loss:

A randomized clinical trial presented at the American Society for Laser Medicine and Surgery found that LLLT accelerated hair recovery by 2.6 times in female breast cancer patients who had completed chemotherapy 1 7 9.
The study included 11 female breast cancer patients aged 20 to 60 who had completed adjuvant chemotherapy 1-4 weeks prior. Baseline hair counts were at a median of 54.6 for the placebo group and 36.5 for the active group1 9.
At 12 weeks, the placebo group’s median hair count was 199.4, while the active group’s was 259.8, representing a 2.8-fold percentage increase for the experimental arm 1 9.
After 24 weeks, patients using active LLLT devices showed significantly higher hair counts (283.5) compared to the placebo group (236.3), demonstrating a 2.6-fold increase in hair counts 1 7 9.
Dr. Raymond Lanzafame, director for the American Society for Laser Medicine and Surgery, noted: “The early results were more dramatic than we had expected” 1 9.
Another study of 106 breast cancer patients showed significant improvements in hair density and diameter with LLLT treatment compared to a control group, and no serious adverse reactions were reported 3.

Treatment Protocols and Devices

Red light therapy for chemotherapy-induced hair loss typically involves:

Devices equipped with 5 milliwatt lasers and 30 LEDs, often in a “bicycle-helmet-like apparatus” 1 9
Treatment sessions lasting 25 minutes 1 9
Treatment frequency of every other day 1 9
Beginning treatment 1-4 weeks after completing chemotherapy 1 9
Continuing treatment for 12-24 weeks 1 9

The iGrow Hair Growth System is one such device used in clinical trials for CIA. Jeff Braile, president of Apira Science (manufacturer of iGrow), stated: “We’ve known for some time that red light effectively treats androgenetic alopecia, but to witness that it can have a similar effect on chemotherapy-induced hair loss is groundbreaking” 1 7 9.

Benefits Beyond Hair Regrowth

Beyond accelerating hair regrowth, red light therapy offers additional benefits for cancer patients:

Non-invasive treatment: Unlike some interventions, red light therapy doesn’t require medications or invasive procedures 5.
Minimal side effects: Clinical trials report no adverse events associated with red light therapy for hair regrowth 1 9.
Improved quality of life: Studies show that patients receiving red light therapy report better global health status and improved body image 3.
Emotional well-being: Hair loss from cancer treatment can take an emotional toll on patients already going through a difficult time. Red light therapy may help alleviate some of this burden 1 9.

Comparing Red Light Therapy to Other CIA Interventions

When compared to other interventions for chemotherapy-induced hair loss, red light therapy offers several advantages:

Cooling caps: While scalp cooling can help prevent hair loss during chemotherapy, it can be uncomfortable and doesn’t work for all chemotherapy regimens. Red light therapy focuses on regrowth rather than prevention.
Minoxidil: Topical minoxidil may help with regrowth but typically takes longer than red light therapy and requires daily application.
Wigs and head coverings: These provide immediate cosmetic solutions but don’t address the underlying issue of hair regrowth.

Future Directions and Research

While initial results are promising, researchers emphasize the need for larger studies to further validate the effectiveness of red light therapy for chemotherapy-induced hair loss 7 9. Current research is exploring:

Optimal treatment protocols (timing, duration, and frequency)
Effectiveness across different chemotherapy regimens
Potential for preventing hair loss during chemotherapy
Combination approaches with other supportive therapies

Conclusion

Red light therapy represents a promising noninvasive approach for accelerating hair regrowth after chemotherapy. Clinical evidence demonstrates its ability to speed recovery by more than 2.5 times compared to natural regrowth, offering hope for cancer patients experiencing the emotional burden of hair loss 1 7 9.

As research continues to evolve, red light therapy may become a standard supportive care option for managing chemotherapy-induced alopecia, helping patients maintain their sense of identity and improving quality of life during cancer treatment and recovery.